Exact Mass: 604.2974
Exact Mass Matches: 604.2974
Found 141 metabolites which its exact mass value is equals to given mass value 604.2974
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Dilazep
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
(1S,2S,3S,4S,4aR,4bR,5aS,6R,6aR,9aR,9bR)-1,2,3,4,4a,4b,5a,6,6a,7,9a,9b-dodecahydro-3,6,6a,9b-tetrahydroxy-5a-(hydroxymethyl)-1,8-dimethyl-3-(1-methylethenyl)-7-oxo-2-(1-oxopropoxy)benz[7,8]azuleno[5,6-b]oxiren-4-yl (2E,4E)-deca-2,4-dienoate|yuanhuaoate C
(1aS,1bR,2aS,3aS,4R,4aS,6S,6aS,7R,8R,11R,12S,13cS)-4,6-bis(acetyloxy)icosahydro-1b,11-dihydroxy-7-(hydroxymethyl)-4a,6a,11,12-tetramethyl-8,12-methanobisoxireno[3,4:6,7]naphtho[2,1:4,5]indeno[1,2-d]oxocin-10(2H)-one|taccalonolide Y
16beta-acetoxystrophanthidin-4,6-dideoxy-2,3-methylenedioxy-beta-D-allopyranoside|reevesioside B
16beta-O-acetyl-scillarenin-3-O-beta-D-glucoside|3-O-beta-Glucopyranoside,16-Ac-3,14,16-Trohydroxybufa-4,20,22-trienolide
cinobufagin 3-O-beta-D-glucopyranoside|cinobufagin 3-O-beta-D-glucoside
Phe Ile Tyr Tyr
Phe Leu Tyr Tyr
Phe Tyr Ile Tyr
Phe Tyr Leu Tyr
Phe Tyr Tyr Ile
Phe Tyr Tyr Leu
Ile Phe Tyr Tyr
Ile Thr Trp Trp
Ile Trp Thr Trp
Ile Trp Trp Thr
Ile Tyr Phe Tyr
Ile Tyr Tyr Phe
Leu Phe Tyr Tyr
Leu Thr Trp Trp
Leu Trp Thr Trp
Leu Trp Trp Thr
Leu Tyr Phe Tyr
Leu Tyr Tyr Phe
Thr Ile Trp Trp
Thr Leu Trp Trp
Thr Trp Ile Trp
Thr Trp Leu Trp
Thr Trp Trp Ile
Thr Trp Trp Leu
Trp Ile Thr Trp
Trp Ile Trp Thr
Trp Leu Thr Trp
Trp Leu Trp Thr
Trp Thr Ile Trp
Trp Thr Leu Trp
Trp Thr Trp Ile
Trp Thr Trp Leu
Trp Trp Ile Thr
Trp Trp Leu Thr
Trp Trp Thr Ile
Trp Trp Thr Leu
Tyr Phe Ile Tyr
Tyr Phe Leu Tyr
Tyr Phe Tyr Ile
Tyr Phe Tyr Leu
Tyr Ile Phe Tyr
Tyr Ile Tyr Phe
Tyr Leu Phe Tyr
Tyr Leu Tyr Phe
Tyr Tyr Phe Ile
Tyr Tyr Phe Leu
Tyr Tyr Ile Phe
Tyr Tyr Leu Phe
ST 26:6;O6;Hex
N,N-Di(4-biphenylyl)-N-(9,9-dimethyl-9H-fluoren-2-yl)-1,4-benzen ediamine
butane-1,4-diol,hexanedioic acid,hexane-1,6-diol,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene
(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoic acid
Dilazep
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
(2S,3S,4S,5Z)-4-(2-carboxyethyl)-5-[2-[[5-[(3-ethenyl-4-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-3-ethyl-4-methyl-1H-pyrrol-2-yl]methyl]-3-methyl-4,5-dioxo-3a,6a-dihydro-1H-cyclopenta[b]pyrrol-6-ylidene]-3-methylpyrrolidine-2-carboxylic acid
1-(1,3-benzodioxol-5-yl)-3-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
2-[[(5S,6R,9R)-5-methoxy-14-[[(2-methoxyanilino)-oxomethyl]amino]-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-8-yl]methyl]benzoic acid
1-(1,3-benzodioxol-5-yl)-3-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
[(1R,2R,3R,4S,5R,6S,7S,9R,10R,11S,14R,15R,16S,24S,26S)-10-hydroxy-9-(hydroxymethyl)-2,14,16-trimethyl-12-oxo-4-prop-1-en-2-yl-8,13,25,27,28,29-hexaoxaoctacyclo[13.10.1.14,24.15,24.111,14.01,6.07,9.011,26]nonacosan-3-yl] acetate
[(1R,2R,3R,4S,5R,6S,7S,9R,10R,11S,14R,15R,16R,24S,26S)-10-hydroxy-9-(hydroxymethyl)-2,14,16-trimethyl-12-oxo-4-prop-1-en-2-yl-8,13,25,27,28,29-hexaoxaoctacyclo[13.10.1.14,24.15,24.111,14.01,6.07,9.011,26]nonacosan-3-yl] acetate
(1r,2r,4s,5r,6r,10r,11r,12s,13s,14s,15s)-13-(acetyloxy)-5,6,11,14-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-15-yl (2e,4e)-deca-2,4-dienoate
(1s,2s,4s,5r,7s,9s,10r,11s,12s,14s,16r,17s,19s)-10-(acetyloxy)-5,17-dihydroxy-16-[(1s)-1-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-11,15-dimethyl-3,8-dioxahexacyclo[10.7.0.0²,⁴.0⁵,¹¹.0⁷,⁹.0¹⁵,¹⁹]nonadecan-14-yl acetate
2-[(4as,5r,8ar)-5-{[(1r,3s,4as,8as)-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-1-hydroxy-2-methoxy-6-methyl-4-oxo-1,5,8,8a-tetrahydronaphthalen-4a-yl]-5,7-dihydroxychromen-4-one
9-(acetyloxy)-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-20-yl acetate
(1r,4s)-4-[(2r,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pentane-1,4-diol
6β-acetoxy scillarenin 3-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN012253","Ingredient_name": "6\u03b2-acetoxy scillarenin 3-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C32H44O11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "278","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}